急性下消化道出血患者的管理:美国胃肠病学会指南更新
本指南采用推荐分级的评估、制定与评价(GRADE)方法,针对急性下消化道出血(LGIB)的风险分层工具、红细胞输注阈值、抗凝药逆转剂、结肠镜与计算机断层扫描血管成像(CTA)等诊断检查、内镜治疗选择及出院后抗血栓药物管理提出推荐。推荐多数需住院结肠镜检查的患者接受非紧急结肠镜检查,因为就诊24小时内紧急结肠镜检查未显示能改善再出血等重要临床结局。
要点
- 推荐使用风险分层工具识别低风险LGIB患者。
- 对危及生命的LGIB且服用维生素K拮抗剂或直接口服抗凝药者,推荐使用逆转剂。
- 严重LGIB中CTA作用增加,并需管理CTA阳性患者。
核心结论
- 多数需住院结肠镜检查的LGIB患者应接受非紧急结肠镜检查,因就诊24小时内紧急结肠镜检查未显示改善再出血等重要临床结局。
- 推荐使用风险分层工具识别低风险LGIB患者。
- 对危及生命的LGIB且服用维生素K拮抗剂或直接口服抗凝药者,推荐使用逆转剂。
- 严重LGIB中CTA作用增加,并需管理CTA阳性患者。
- 提供停用LGIB后恢复抗血小板和抗凝药物的更新推荐。
研究设计与样本
- 美国胃肠病学会(ACG)制定的指南更新,采用推荐分级的评估、制定与评价(GRADE)方法。
关键数值与推荐
- 推荐使用风险分层工具识别低风险LGIB患者。
- 对危及生命的LGIB且服用维生素K拮抗剂和直接口服抗凝药者,推荐使用逆转剂。
- 严重LGIB中CTA作用增加,并需管理CTA阳性患者。
- 推荐多数需住院结肠镜检查的患者接受非紧急结肠镜检查。
- 提供停用LGIB后恢复抗血小板和抗凝药物的更新推荐。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute lower gastrointestinal bleeding (LGIB) is a common reason for hospitalization in the United States and is associated with significant utilization of hospital resources, as well as considerable morbidity and mortality. These revised guidelines implement the Grading of Recommendations, Assessment, Development, and Evaluation methodology to propose recommendations for the use of risk stratification tools, thresholds for red blood cell transfusion, reversal agents for patients on anticoagulants, diagnostic testing including colonoscopy and computed tomography angiography (CTA), endoscopic therapeutic options, and management of antithrombotic medications after hospital discharge. Important changes since the previous iteration of this guideline include recommendations for the use of risk stratification tools to identify patients with LGIB at low risk of a hospital-based intervention, the role for reversal agents in patients with life-threatening LGIB on vitamin K antagonists and direct oral anticoagulants, the increasing role for CTA in patients with severe LGIB, and the management of patients who have a positive CTA. We recommend that most patients requiring inpatient colonoscopy undergo a nonurgent colonoscopy because performing an urgent colonoscopy within 24 hours of presentation has not been shown to improve important clinical outcomes such as rebleeding. Finally, we provide updated recommendations regarding resumption of antiplatelet and anticoagulant medications after cessation of LGIB.
引用
- Sengupta N, Feuerstein JD, Jairath V, et al. Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline. Am J Gastroenterol. 2022. PMID: 36735555. doi:10.14309/ajg.0000000000002130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。